Overview

Full Product Details

9780199737468

Table of Contents

Reviews

""Is the timing right for this sort of publication? Probably. As the title implies a fall has occurred so it is hard to say whether it will be of interest. In reality I would say rise, fall, another rise with the concept of CRH antagonists for depression in the 1990s and in the past couple of years (peaking now) another all because they don't work for depression. Dr. Fink is an internationally known expert on ECT. . . . I would buy a copy and enjoyed reading the chapters provided."" --E. Sherwood Brown, M.D., P.h.D Associate Professor, Director, Psychoneuroendocrine Research Program, Department of Psychiatry, University of Texas Southwestern Medical Center Dallas, TX ""Dr. Max Fink is one of the originators of modern psychiatric therapeutics, and his historical perspectives would be of interest. I personally would buy this book."" --Owen M. Wolkowitz, MD Professor of Psychiatry, UCSF School of Medicine San Francisco, CA ""With a strategic organization, the book effectively provides the necessary introduction in the first several chapters, while the latter chapters present the challenges and shortcomings of endocrine psychiatry."" --Doody's

<br> Is the timing right for this sort of publication? Probably. As the title implies a fall has occurred so it is hard to say whether it will be of interest. In reality I would say rise, fall, another rise with the concept of CRH antagonists for depression in the 1990s and in the past couple of years (peaking now) another all because they don't work for depression. Dr. Fink is an internationally known expert on ECT. . . . I would buy a copy and enjoyed reading the chapters provided. <br>--E. Sherwood Brown, M.D., P.h.D <br>Associate Professor, Director, Psychoneuroendocrine Research Program, <br>Department of Psychiatry, University of Texas Southwestern Medical Center <br>Dallas, TX<p><br> Dr. Max Fink is one of the originators of modern psychiatric therapeutics, and his historical perspectives would be of interest. I personally would buy this book. <br>--Owen M. Wolkowitz, MD <br>Professor of Psychiatry, UCSF School of Medicine <br>San Francisco, CA<p><br> With a strategic organization, the book effectively provides the necessary introduction in the first several chapters, while the latter chapters present the challenges and shortcomings of endocrine psychiatry. --Doody's<br><p><br>

Is the timing right for this sort of publication? Probably. As the title implies a fall has occurred so it is hard to say whether it will be of interest. In reality I would say rise, fall, another rise with the concept of CRH antagonists for depression in the 1990s and in the past couple of years (peaking now) another all because they don't work for depression. Dr. Fink is an internationally known expert on ECT. . . . I would buy a copy and enjoyed reading the chapters provided. --E. Sherwood Brown, M.D., P.h.D Associate Professor, Director, Psychoneuroendocrine Research Program, Department of Psychiatry, University of Texas Southwestern Medical Center Dallas, TX Dr. Max Fink is one of the originators of modern psychiatric therapeutics, and his historical perspectives would be of interest. I personally would buy this book. --Owen M. Wolkowitz, MD Professor of Psychiatry, UCSF School of Medicine San Francisco, CA With a strategic organization, the book effectively provides the necessary introduction in the first several chapters, while the latter chapters present the challenges and shortcomings of endocrine psychiatry. --Doody's Is the timing right for this sort of publication? Probably. As the title implies a fall has occurred so it is hard to say whether it will be of interest. In reality I would say rise, fall, another rise with the concept of CRH antagonists for depression in the 1990s and in the past couple of years (peaking now) another all because they don't work for depression. Dr. Fink is an internationally known expert on ECT. . . . I would buy a copy and enjoyed reading the chapters provided. --E. Sherwood Brown, M.D., P.h.D Associate Professor, Director, Psychoneuroendocrine Research Program, Department of Psychiatry, University of Texas Southwestern Medical Center Dallas, TX Dr. Max Fink is one of the originators of modern psychiatric therapeutics, and his historical perspectives would be of interest. I personally would buy this book. --Owen M. Wolkowitz, MD Professor of Psychiatry, UCSF School of Medicine San Francisco, CA With a strategic organization, the book effectively provides the necessary introduction in the first several chapters, while the latter chapters present the challenges and shortcomings of endocrine psychiatry. --Doody's

Author Information

Edward Shorter, PhD Professor of the History of Medicine Hannah Chair in the History of Medicine Professor of Psychiatry Faculty of MedicineUniversity of Toronto Max Fink, MD Professor of Psychiatry and Neurology Emeritus School of Medicine State University of New York at Stony Brook New York, NY

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available